Usefulness of triggering receptor expressed on myeloid cells-1 in differentiating between typical and atypical community-acquired pneumonia

American Journal of Emergency Medicine

Volumn 29, Issue 6, 2011, Pages 626-631

  How, Chorng Kuang ^a,b   Hou, Sen Kuang ^b   Shih, Hsin Chin ^a,b   Yen, David Hung Tsang ^a,b   Huang, Chun I ^a,b   Lee, Chen Hsen ^a,b   Tang, Gau Jun ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ADULT; ARTICLE; ATYPICAL COMMUNITY ACQUIRED PNEUMONIA; BACTERIAL PNEUMONIA; BONE MARROW CELL; CELL DIFFERENTIATION; CELL SURFACE; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; LEGIONELLA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTICENTER STUDY; MYCOPLASMA PNEUMONIAE; NEUTROPHIL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TYPICAL COMMUNITY ACQUIRED PNEUMONIA;

BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYELOID CELLS; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; ROC CURVE; STATISTICS, NONPARAMETRIC;

EID: 79959431087     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2010.01.010     Document Type: Article

References (20)

1. Halm E.A., and Teirstein A.S. Management of community-acquired pneumonia N Engl J Med 347 2002 2039 2045 (Pubitemid 35461661)
2. Masia M., Gutierrez F., and Padilla S. Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors Clin Microbiol Infect 13 2007 153 161 (Pubitemid 46115655)
3. Korppi M., Don M., and Valent F. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children Acta Paediatr 97 2008 943 947 (Pubitemid 351792810)
4. Kuti J.L., Capitano B., and Nicolau D.P. Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance Pharmacoeconomics 20 2002 513 528 (Pubitemid 34848337)
5. Oosterheert J.J., Bonten M.J., and Hak E. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systemic review J Antimicrob Chemother 52 2003 555 563 (Pubitemid 37258413)
6. Doern G.V., and Brown S.D. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01 J Infect 48 2004 56 65 (Pubitemid 38072202)
7. Wang J.Y., Hsueh P.R., and Jan I.S. Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas Thorax 61 2006 903 908
8. Brown J.S. Biomarkers and community-acquired pneumonia Thorax 64 2009 556 558
9. Bouchon A., Facchetti F., and Weigand M.A. TREM-1 amplifies inflammation and is a crucial mediator of septic shock Nature 410 2001 1103 1107 (Pubitemid 32391042)
10. Colonna M. TREMs in the immune system and beyond Nat Rev Immunol 6 2003 445 453 (Pubitemid 37339184)
11. Gibot S., Kolopp-Sarda M.N., and Bene M.C. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis Ann Intern Med 141 2004 9 15
12. Gibot S., Le Renard P.E., and Bollaert P.E. Surface triggering receptor expressed on myeloid cells 1 expressed patterns in septic shock Intensive Care Med 31 2005 594 597 (Pubitemid 40543894)
13. Richeldi L., Mariani M., and Losi M. Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections Eur Respir J 24 2004 247 250 (Pubitemid 39139791)
14. How C.K., Chern C.H., and Wu M.F. Expression of the triggering receptor expressed on myeloid cells-1 mRNA in a heterogeneous infected population Int J Clin Pract 63 2009 126 133
15. Lim W.S., van der Eerden M.M., and Laing R. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 2003 377 382 (Pubitemid 36560938)
16. Garau J., and Calbo E. Community-acquired pneumonia Lancet 371 2008 455 458 (Pubitemid 351199874)
17. Kruger S., Ewig S., and Papassotiriou J. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ Respir Res 10 2009 65
18. Tejera A., Santolaria F., and Diez M.L. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response Cytokine 38 2007 117 123 (Pubitemid 47248295)
19. Ford J.W., and McVicar D.W. TREM and TREM-like receptors in inflammation and disease Curr Opin Immunol 21 2009 38 46
20. Sterne J.A., Gavaghan D., and Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature J Clin Epidemiol 53 2000 1119 1129